Brikun, Igor
Nusskern, Deborah
Decatus, Andrew
Harvey, Eric
Li, Lin
Freije, Diha http://orcid.org/0000-0002-5158-7943
Funding for this research was provided by:
National Cancer Institute (R43CA165444)
Article History
Received: 13 February 2018
Accepted: 21 June 2018
First Online: 3 July 2018
Ethics approval and consent to participate
: The study was reviewed and approved by the Western Institutional Review Board (WIRB, study # 1139453, Puyallup, WA). All patients signed the consent form approved by the IRB prior to sample collection. All patient identifiers were removed in the clinics before urine samples were shipped to the laboratory.
: Not applicable.
: IB and DF are members and employees of Euclid Diagnostics LLC. DN is a member of Euclid Diagnostics. IB, DN, and DF have patent applications covering some of the markers in this study. LL, AD, and EH declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.